FENC
Fennec Pharmaceuticals (FENC)
$02
About Fennec Pharmaceuticals (FENC)
Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Details
Daily high
$11.06
Daily low
$10.44
Price at open
$10.56
52 Week High
$11.06
52 Week Low
$5.65
Market cap
366.5M
Dividend yield
0.00%
Volume
1.1M
Avg. volume
264,497
P/E ratio
-35.62
Fennec Pharmaceuticals News
Details
Daily high
$11.06
Daily low
$10.44
Price at open
$10.56
52 Week High
$11.06
52 Week Low
$5.65
Market cap
366.5M
Dividend yield
0.00%
Volume
1.1M
Avg. volume
264,497
P/E ratio
-35.62